These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 989475)

  • 21. Pharmacokinetics of terbutaline given in slow-release tablets.
    Nyberg L; Kennedy BM
    Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of oral glycerol-1-nitrate.
    Laufen H; Leitold M; Yeates RA
    Eur J Clin Pharmacol; 1986; 31(2):169-75. PubMed ID: 3100313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
    Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
    J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup.
    Dahl SG; Strandjord RE; Sigfusson S
    Eur J Clin Pharmacol; 1977 Apr; 11(4):305-10. PubMed ID: 862652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of bromhexine tablets and preliminary pharmacokinetics in humans.
    Bechgaard E; Nielsen A
    Biopharm Drug Dispos; 1982; 3(4):337-44. PubMed ID: 6897618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the pharmacokinetics of phenacetin in man.
    Raaflaub J; Dubach UC
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):261-5. PubMed ID: 1233222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of food on the absorption of slow-release isosorbide-5-mononitrate tablets.
    Thomson AH; Miller SH; Green ST; Whiting B
    Eur J Clin Pharmacol; 1988; 34(1):47-50. PubMed ID: 3360048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and dose proportionality of domperidone in healthy volunteers.
    Huang YC; Colaizzi JL; Bierman RH; Woestenborghs R; Heykants JJ
    J Clin Pharmacol; 1986; 26(8):628-32. PubMed ID: 3793955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
    Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
    Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers.
    Hedner T; Hedner J; Gelin-Friberg A; Huang ML; Van de Poel S; Woestenborghs R; Van Peer A; Heykants J
    Eur J Clin Pharmacol; 1990; 38(6):629-31. PubMed ID: 2373139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The absolute bioavailability of caffeine in man.
    Blanchard J; Sawers SJ
    Eur J Clin Pharmacol; 1983; 24(1):93-8. PubMed ID: 6832208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation.
    Johansson ED; Johansen PB; Rasmussen SN
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):311-7. PubMed ID: 2943134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability of three cefixime formulations.
    Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
    Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
    Olsson B; Johansson M; Gabrielsson J; Bolme P
    Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.